Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018587 · ClinicalTrials.gov registry record · NA
Feasibility Study of the TruSculpt Radiofrequency Device
A NA study of Tissue Tightening, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03018587: Completed NA study of Tissue Tightening, sponsored by Cutera.
NCT03018587 is a NA study of Tissue Tightening that has completed, run by Cutera. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03018587, a NA study of Tissue Tightening, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
A single-center, prospective, open-label feasibility study of the truSculpt radiofrequency device.
Primary Outcome
Degree of improvement in the treatment area at 12 weeks post-treatment compared with Baseline photo as assessed by the Investigator using Global Aesthetic Improvement Scale(GAIS): 4 = Very Significant Improvement (\>75%), 3 = Significant Improvement (51 - 75%), 2 = Moderate Improvement (26 - 50%), 1 = Mild Improvement (5 - 25%), or 0 = No Change (\<5%)
Conditions Studied
Interventions
- DEVICE TruSculpt
Study Locations (1)
California
- Cutera Research Center - Brisbane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-12-29 |
| Phase | NA |
What the finished NCT03018587 record still lists
NCT03018587 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Tissue Tightening appearing as the primary indexed condition, and to 1 intervention - of which TruSculpt is the first listed.
NCT03018587 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03018587 about?
NCT03018587 is a clinical study titled "Feasibility Study of the TruSculpt Radiofrequency Device". A single-center, prospective, open-label feasibility study of the truSculpt radiofrequency device.
What is the current status of trial NCT03018587?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-01. Estimated completion is 2017-12-29.
What conditions does trial NCT03018587 study?
This clinical trial studies the following conditions: Tissue Tightening.
What interventions are being tested in trial NCT03018587?
The interventions under investigation include: TruSculpt (DEVICE).
Who is sponsoring clinical trial NCT03018587?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03018587 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03018587's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia